7
May
2024

KD Pharma Group

Exhibitor at CPHI North America 2024 stand 800
About Us

KD Pharma is a contract manufacturer that develops products in the pharmaceutical space by employing state-of-the-art technology. Since its inception in 1988, KD Pharma has focused on utilizing cutting edge technologies to develop and manufacture exceptional quality APIs. These twin pillars of technology and quality are the foundation of the KD Pharma CDMO Division.
KD Pharma’s world-class synthesis and fractionation facility in the UK has a long track record in API production. Flexible multi-purpose ...

  • CH
  • 2021
    On CPHI since
  • 250 - 499
    Employees
Company types
CMO/CDMO
Contract Service
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Analytical Services
API Producer
Chemical Development
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Fine Chemicals Company
Generic APIs producer
Intermediates Manufacturer
Pharmaceutical Company (generic finished products)
Contact info
Event information
CPHI North America 2024
  • 07 May 2024 - 09 May 2024
  • Pennsylvania Convention Center, Philadelphia
  • Visit us at stand 800

Products Featured at CPHI North America 2024

  • CONTRACT MANUFACTURING - SMALL MOLECULES

    Product CONTRACT MANUFACTURING - SMALL MOLECULES

    KD Pharma’s professional expertise, state-of-the-art assets and proven track record in regulatory compliance allow us to become your preferred CDMO solutions partner.

    Your Agile Experts
    • Responsive to our customers’ needs in a more dynamic customer-centric way • Adaptive to the most diverse re...
  • ASYMMETRIC HYDROGENATION

    Product ASYMMETRIC HYDROGENATION

    We extensively address the specific needs of the pharmaceutical, food, cosmetics, agrochemicals and specialty chemicals industries with our capabilities in Transition Metal Catalysis (TMC) as applied to asymmetric hydrogenation. Complex active pharmaceutical ingredients (API’s) are often stereochemica...
  • API & INTERMEDIATES

    Product API & INTERMEDIATES

    The CDMO Division of KD Pharma excels in the production of drug intermediates and API drug substances. We offer our customers the full spectrum of drug services: • R&D development material for preclinical studies       • Pilot plant for phase I, II and III supplies • Large scale p...
  • HIGH-PRESSURE HYDROGENATION

    Product HIGH-PRESSURE HYDROGENATION

    Sophisticated reduction technologies:The CDMO Division of KD Pharma operates highly corrosion resistant Inconel® facilities to perform hydrogenation under pressure up to 64 bar (928 psig) and temperatures up to 150°C from lab to industrial scale (4 m3). Both homogeneous as well as heterogene...
  • SIMULATED MOVING BED CHROMATOGRAPHY (SMB)

    Product SIMULATED MOVING BED CHROMATOGRAPHY (SMB)

    KD Pharma is a contract manufacturer that develops products in the pharmaceutical space by employing state-of-the-art technology. Since its inception in 1988, KD Pharma has focused on utilizing cutting edge technologies to develop and manufacture exceptional quality APIs. These twin pillars of technology a...
  • CARBONYLATION / C-C & C-N COUPLING

    Product CARBONYLATION / C-C & C-N COUPLING

    We extensively address the specific needs of the pharmaceutical, food, cosmetics, agrochemicals and specialty chemicals industries with our capabilities in Transition Metal Catalysis (TMC). Complex active pharmaceutical ingredients (API’s) are often stereochemically demanding: use of modern synthetic metho...
  • CYANATION OF ANILINES AND HALOAROMATICS

    Product CYANATION OF ANILINES AND HALOAROMATICS

    KD Pharma has been performing a number of different cyanation reactions on industrial scale. Among those, cost efficient and selective cyanation of amino-aromatics through diazotization and subsequent Sandmeyer reaction is standard practice.In addition, Copper(II)-promoted direct cyanation of haloaromatics...
  • DISTILLATION

    Product DISTILLATION

    Modern distillation technologies:The CDMO Division of KD Pharma operates different multifunctional distillation facilities from pilot scale to industrial scale volumes. In combination with KD Pharma’s outstanding and highly flexible manufacturing capabilities, we can produce various high purity liquid prod...
  • HAZARDOUS AND MALODOROUS CHEMISTRIES

    Product HAZARDOUS AND MALODOROUS CHEMISTRIES

    The CDMO Division of KD Pharma have years of experience with challenging chemistries involving toxicity, odor, industrial hygiene and environmental protection. We are experts handling these problematic chemistries and have over time made appropriate provisions to control these hazards as to work in fu...